Acute Respiratory Distress Syndrome News and Research

RSS
Clinical trial to investigate statins in patients with acute severe respiratory failure

Clinical trial to investigate statins in patients with acute severe respiratory failure

Lower rate of reintubation observed in infants receiving SURFAXIN

Lower rate of reintubation observed in infants receiving SURFAXIN

Cognitive and psychiatric impairments common among long-term ALI survivors

Cognitive and psychiatric impairments common among long-term ALI survivors

Adjusting ventilator to keep breath size and lung pressures lower can reduce death from lung injury

Adjusting ventilator to keep breath size and lung pressures lower can reduce death from lung injury

Experts highlight latest advances in use of biomarkers in various diseases

Experts highlight latest advances in use of biomarkers in various diseases

FDA approves Discovery Labs' SURFAXIN to prevent Respiratory Distress Syndrome

FDA approves Discovery Labs' SURFAXIN to prevent Respiratory Distress Syndrome

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

GSK initiates rhACE2 phase IIa study for Acute Lung Injury

Scientists identify how cells reduce tissue damage from inflammation in ALI model

Scientists identify how cells reduce tissue damage from inflammation in ALI model

NewYork-Presbyterian/Columbia opens Center for Acute Respiratory Failure

NewYork-Presbyterian/Columbia opens Center for Acute Respiratory Failure

Research breakthrough in lung regeneration

Research breakthrough in lung regeneration

Researchers identify stem cells responsible for lung regeneration

Researchers identify stem cells responsible for lung regeneration

Breakthrough in development of effective therapy against Hendra virus

Breakthrough in development of effective therapy against Hendra virus

Researchers awarded $12M to study pathology of severe lung injury

Researchers awarded $12M to study pathology of severe lung injury

Altor receives NHLBI SBIR grant to complete ALT-836 second Phase 2 trial in ALI/ARDS

Altor receives NHLBI SBIR grant to complete ALT-836 second Phase 2 trial in ALI/ARDS

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Tarix begins patient enrollment for TXA127 Phase 1 study in DCBT

Binge drinking can alter body's immune system response to orthopaedic injury

Binge drinking can alter body's immune system response to orthopaedic injury

Survivors of severe critical illness requiring intensive care do not regain physical or psychological health

Survivors of severe critical illness requiring intensive care do not regain physical or psychological health

Corticosteroids may decrease occurrence of hospital-acquired pneumonia in ICU patients

Corticosteroids may decrease occurrence of hospital-acquired pneumonia in ICU patients

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

First patient enrolled in TXA127 Phase 2 clinical study to stimulate engraftment following transplant

NTI awards $295,172 to BMC chief for acute lung injury study

NTI awards $295,172 to BMC chief for acute lung injury study